A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Inclusion Criteria: * Ages Eligible for Study: 18 Years to 70 Years * Genders Eligible for Study: Both * Accepts Healthy Volunteers: No Criteria * Subject is between 18 and 70 years of age, inclusive. * Definite MS by the revised McDonald criteria (2005) (Appendix A), with a Secondary Progressive course. * Expanded Disability Status Scale (EDSS) \>=score 3.5 (Appendix B). * Two or more documented clinical relapses of MS in the preceding 24 months OR one documented clinical relapse of MS in the preceding 1 2 months prior to screening . * Laboratory values within the following limits: * Creatinine 1 . 5 x high normal. * Hemoglobin Exclusion Criteria: * Subjects currently prescribed Campath or Lemtrada